PYPDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

PolyPid Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 25, 2026

$4.88+0.16 (+3.39%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): 2.3
Dividend yield: –

PolyPid Ltd. cash flow statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Stock-Based Compensation	4.85	2.82	3.39	4.31	4.75	4.58	0.98	1.00
Other Non-Cash Items	–	-0.70	-1.73	-0.29	–	–	–	–
Change in Accounts Payable	0.18	1.64	-0.37	-3.10	2.22	-0.61	0.45	-0.89
Change in Unearned Revenue	–	–	–	2.55	–	–	–	–
Operating Cash Flow	-28	-22	-17	-34	-32	-22	-17	-17
Capital Expenditures	-0.21	-0.08	-0.20	-1.77	-2.65	-0.78	-0.88	-3.07
Purchase of Investments	-26	-21	-19	-7.00	-8.00	–	–	–
Investing Cash Flow	-6.70	-0.33	3.80	17	37	-41	-24	11
Stock Issued	0.53	–	8.72	4.42	–	–	–	–
Debt Issued	–	–	–	12	–	–	–	–
Debt Repaid	-6.38	-3.32	-2.62	-0.40	–	–	–	–
Financing Cash Flow	25	32	9.98	16	1.03	63	38	9.39
Net Change in Cash	-9.21	10	-3.46	–	–	–	–	–
Free Cash Flow	-28	-22	-17	-36	-35	-22	-18	-20
Income Taxes Paid	0.01	0.00	0.02	0.01	–	–	–	–
Interest Paid	0.56	0.95	1.04	0.73	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -366.3%

Financial strength

Current ratio: 1.35
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 99.4%

Valuation

P/E ratio: 2.3
Price to sales: –
Price to book: –
Dividend yield: –